Research & Development



  霍去病稍微思量一下,就對雲瑯道︰“我們就去鉤子山,不過,那里沒有水源,還是一個孤零零的山包,與白登山互為犄角,卻一直沒有駐軍。阿瑯,你要想辦法解決水源問題,只要水源問題解決了,鉤子山雖說不到白登山的一成大,就重要性而言,有過之而無不及。”   霍去病站起來之後就拉住那個傳令官要求見謝長川。av在线观看   畢竟,這樣的巨木,不是哪里都有的,即便是有,也不好運輸到工地上。超碰在线视频人人av   雲瑯看看傳令官道︰“你覺得鉤子山能打出水井來麼?”   明明想要把霍去病這群人安排去鉤子山,卻不願意明說,非要讓霍去病他們自己提出來才答應。人人日人人爱   李敢猶在帶著部下追逐四散的匈奴騎兵,忽然听到一聲清脆的鑼聲,循聲望去,卻看見雲瑯站在最高處死命的敲鑼。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo